nodes	percent_of_prediction	percent_of_DWPC	metapath
Mafenide—CA9—breast cancer	0.741	1	CbGaD
Mafenide—Dapsone—NAT2—breast cancer	0.00155	0.356	CrCbGaD
Mafenide—Haemoglobin—Fulvestrant—breast cancer	0.00132	0.00708	CcSEcCtD
Mafenide—Haemorrhage—Fulvestrant—breast cancer	0.00131	0.00704	CcSEcCtD
Mafenide—Blister—Fluorouracil—breast cancer	0.0013	0.00694	CcSEcCtD
Mafenide—Pancytopenia—Ixabepilone—breast cancer	0.00128	0.00685	CcSEcCtD
Mafenide—Haemolytic anaemia—Chlorambucil—breast cancer	0.00125	0.00669	CcSEcCtD
Mafenide—Haemoglobin—Exemestane—breast cancer	0.00115	0.00615	CcSEcCtD
Mafenide—Pancytopenia—Idarubicin—breast cancer	0.00114	0.00612	CcSEcCtD
Mafenide—Haemorrhage—Exemestane—breast cancer	0.00114	0.00612	CcSEcCtD
Mafenide—Swelling—Tamoxifen—breast cancer	0.00114	0.00609	CcSEcCtD
Mafenide—Sulfanilamide—CA9—breast cancer	0.00109	0.25	CrCbGaD
Mafenide—Haemolytic anaemia—Melphalan—breast cancer	0.00109	0.00583	CcSEcCtD
Mafenide—Swelling—Goserelin—breast cancer	0.00109	0.00582	CcSEcCtD
Mafenide—Haemoglobin—Ixabepilone—breast cancer	0.00108	0.0058	CcSEcCtD
Mafenide—Haemorrhage—Ixabepilone—breast cancer	0.00108	0.00577	CcSEcCtD
Mafenide—Dermatitis bullous—Tamoxifen—breast cancer	0.00105	0.00562	CcSEcCtD
Mafenide—Haemoglobin—Anastrozole—breast cancer	0.00102	0.00546	CcSEcCtD
Mafenide—Haemoglobin—Letrozole—breast cancer	0.00102	0.00546	CcSEcCtD
Mafenide—Haemorrhage—Anastrozole—breast cancer	0.00101	0.00543	CcSEcCtD
Mafenide—Haemorrhage—Letrozole—breast cancer	0.00101	0.00543	CcSEcCtD
Mafenide—Burning sensation—Docetaxel—breast cancer	0.000971	0.0052	CcSEcCtD
Mafenide—Haemoglobin—Idarubicin—breast cancer	0.000968	0.00518	CcSEcCtD
Mafenide—Bone marrow depression—Capecitabine—breast cancer	0.000967	0.00518	CcSEcCtD
Mafenide—Haemorrhage—Idarubicin—breast cancer	0.000963	0.00516	CcSEcCtD
Mafenide—Pancytopenia—Chlorambucil—breast cancer	0.000925	0.00496	CcSEcCtD
Mafenide—Pain—Carboplatin—breast cancer	0.000921	0.00493	CcSEcCtD
Mafenide—Blister—Capecitabine—breast cancer	0.000906	0.00485	CcSEcCtD
Mafenide—Dermatitis bullous—Vinorelbine—breast cancer	0.000898	0.00481	CcSEcCtD
Mafenide—Erythema—Anastrozole—breast cancer	0.000883	0.00473	CcSEcCtD
Mafenide—Pancytopenia—Vinblastine—breast cancer	0.000848	0.00454	CcSEcCtD
Mafenide—Pancytopenia—Tamoxifen—breast cancer	0.000824	0.00441	CcSEcCtD
Mafenide—Pancytopenia—Melphalan—breast cancer	0.000807	0.00432	CcSEcCtD
Mafenide—Swelling—Mitoxantrone—breast cancer	0.000803	0.0043	CcSEcCtD
Mafenide—Pain—Fulvestrant—breast cancer	0.000799	0.00428	CcSEcCtD
Mafenide—Pain—Toremifene—breast cancer	0.000788	0.00422	CcSEcCtD
Mafenide—Swelling—Fluorouracil—breast cancer	0.000769	0.00412	CcSEcCtD
Mafenide—Urticaria—Fulvestrant—breast cancer	0.000742	0.00397	CcSEcCtD
Mafenide—Dermatitis bullous—Gemcitabine—breast cancer	0.000722	0.00387	CcSEcCtD
Mafenide—Bone marrow depression—Methotrexate—breast cancer	0.00072	0.00386	CcSEcCtD
Mafenide—Pruritus—Lapatinib—breast cancer	0.000719	0.00385	CcSEcCtD
Mafenide—Haemoglobin—Vinblastine—breast cancer	0.000718	0.00385	CcSEcCtD
Mafenide—Haemorrhage—Vinblastine—breast cancer	0.000715	0.00383	CcSEcCtD
Mafenide—Dermatitis bullous—Fluorouracil—breast cancer	0.00071	0.0038	CcSEcCtD
Mafenide—Pancytopenia—Vinorelbine—breast cancer	0.000705	0.00377	CcSEcCtD
Mafenide—Burning sensation—Methotrexate—breast cancer	0.0007	0.00375	CcSEcCtD
Mafenide—Haemoglobin—Tamoxifen—breast cancer	0.000698	0.00374	CcSEcCtD
Mafenide—Diarrhoea—Lapatinib—breast cancer	0.000695	0.00372	CcSEcCtD
Mafenide—Haemorrhage—Tamoxifen—breast cancer	0.000694	0.00372	CcSEcCtD
Mafenide—Pain—Exemestane—breast cancer	0.000694	0.00372	CcSEcCtD
Mafenide—Haemoglobin—Melphalan—breast cancer	0.000683	0.00366	CcSEcCtD
Mafenide—Haemorrhage—Melphalan—breast cancer	0.00068	0.00364	CcSEcCtD
Mafenide—Bone marrow depression—Epirubicin—breast cancer	0.000674	0.00361	CcSEcCtD
Mafenide—Pancytopenia—Thiotepa—breast cancer	0.000673	0.0036	CcSEcCtD
Mafenide—Haemoglobin—Goserelin—breast cancer	0.000667	0.00357	CcSEcCtD
Mafenide—Face oedema—Gemcitabine—breast cancer	0.000666	0.00357	CcSEcCtD
Mafenide—Haemorrhage—Goserelin—breast cancer	0.000663	0.00355	CcSEcCtD
Mafenide—Hyperventilation—Epirubicin—breast cancer	0.000661	0.00354	CcSEcCtD
Mafenide—Pruritus—Fulvestrant—breast cancer	0.000661	0.00354	CcSEcCtD
Mafenide—Burning sensation—Epirubicin—breast cancer	0.000655	0.00351	CcSEcCtD
Mafenide—Pain—Ixabepilone—breast cancer	0.000655	0.00351	CcSEcCtD
Mafenide—Swelling—Paclitaxel—breast cancer	0.000655	0.00351	CcSEcCtD
Mafenide—Pruritus—Toremifene—breast cancer	0.000652	0.00349	CcSEcCtD
Mafenide—Urticaria—Exemestane—breast cancer	0.000645	0.00345	CcSEcCtD
Mafenide—Rash—Lapatinib—breast cancer	0.00064	0.00343	CcSEcCtD
Mafenide—Dermatitis—Lapatinib—breast cancer	0.00064	0.00343	CcSEcCtD
Mafenide—Diarrhoea—Fulvestrant—breast cancer	0.000639	0.00342	CcSEcCtD
Mafenide—Blister—Epirubicin—breast cancer	0.000631	0.00338	CcSEcCtD
Mafenide—Bone marrow depression—Doxorubicin—breast cancer	0.000623	0.00334	CcSEcCtD
Mafenide—Pain—Anastrozole—breast cancer	0.000616	0.0033	CcSEcCtD
Mafenide—Pain—Letrozole—breast cancer	0.000616	0.0033	CcSEcCtD
Mafenide—Hyperventilation—Doxorubicin—breast cancer	0.000612	0.00328	CcSEcCtD
Mafenide—Burning sensation—Doxorubicin—breast cancer	0.000606	0.00324	CcSEcCtD
Mafenide—Erythema—Tamoxifen—breast cancer	0.000604	0.00324	CcSEcCtD
Mafenide—Rash—Fulvestrant—breast cancer	0.000589	0.00315	CcSEcCtD
Mafenide—Dermatitis—Fulvestrant—breast cancer	0.000588	0.00315	CcSEcCtD
Mafenide—Pain—Raloxifene—breast cancer	0.000585	0.00313	CcSEcCtD
Mafenide—Blister—Doxorubicin—breast cancer	0.000584	0.00313	CcSEcCtD
Mafenide—Rash—Toremifene—breast cancer	0.000581	0.00311	CcSEcCtD
Mafenide—Pancytopenia—Mitoxantrone—breast cancer	0.000581	0.00311	CcSEcCtD
Mafenide—Dermatitis—Toremifene—breast cancer	0.000581	0.00311	CcSEcCtD
Mafenide—Eosinophilia—Fluorouracil—breast cancer	0.00058	0.00311	CcSEcCtD
Mafenide—Erythema—Goserelin—breast cancer	0.000577	0.00309	CcSEcCtD
Mafenide—Pruritus—Exemestane—breast cancer	0.000574	0.00307	CcSEcCtD
Mafenide—Urticaria—Anastrozole—breast cancer	0.000573	0.00307	CcSEcCtD
Mafenide—Urticaria—Letrozole—breast cancer	0.000573	0.00307	CcSEcCtD
Mafenide—Haemoglobin—Thiotepa—breast cancer	0.00057	0.00305	CcSEcCtD
Mafenide—Haemorrhage—Thiotepa—breast cancer	0.000567	0.00304	CcSEcCtD
Mafenide—Pancytopenia—Gemcitabine—breast cancer	0.000566	0.00303	CcSEcCtD
Mafenide—Pancytopenia—Fluorouracil—breast cancer	0.000557	0.00298	CcSEcCtD
Mafenide—Diarrhoea—Exemestane—breast cancer	0.000555	0.00297	CcSEcCtD
Mafenide—Swelling—Docetaxel—breast cancer	0.000555	0.00297	CcSEcCtD
Mafenide—Urticaria—Idarubicin—breast cancer	0.000544	0.00291	CcSEcCtD
Mafenide—Pruritus—Ixabepilone—breast cancer	0.000542	0.0029	CcSEcCtD
Mafenide—Swelling—Capecitabine—breast cancer	0.000537	0.00288	CcSEcCtD
Mafenide—Haemolytic anaemia—Capecitabine—breast cancer	0.000525	0.00281	CcSEcCtD
Mafenide—Diarrhoea—Ixabepilone—breast cancer	0.000524	0.00281	CcSEcCtD
Mafenide—Erythema—Vinorelbine—breast cancer	0.000517	0.00277	CcSEcCtD
Mafenide—Dermatitis bullous—Docetaxel—breast cancer	0.000512	0.00274	CcSEcCtD
Mafenide—Rash—Exemestane—breast cancer	0.000512	0.00274	CcSEcCtD
Mafenide—Dermatitis—Exemestane—breast cancer	0.000511	0.00274	CcSEcCtD
Mafenide—Pruritus—Anastrozole—breast cancer	0.00051	0.00273	CcSEcCtD
Mafenide—Pruritus—Letrozole—breast cancer	0.00051	0.00273	CcSEcCtD
Mafenide—Dermatitis bullous—Capecitabine—breast cancer	0.000496	0.00266	CcSEcCtD
Mafenide—Erythema—Thiotepa—breast cancer	0.000494	0.00264	CcSEcCtD
Mafenide—Diarrhoea—Anastrozole—breast cancer	0.000493	0.00264	CcSEcCtD
Mafenide—Diarrhoea—Letrozole—breast cancer	0.000493	0.00264	CcSEcCtD
Mafenide—Haemoglobin—Irinotecan—breast cancer	0.000492	0.00264	CcSEcCtD
Mafenide—Haemoglobin—Mitoxantrone—breast cancer	0.000492	0.00264	CcSEcCtD
Mafenide—Haemorrhage—Irinotecan—breast cancer	0.00049	0.00262	CcSEcCtD
Mafenide—Haemorrhage—Mitoxantrone—breast cancer	0.00049	0.00262	CcSEcCtD
Mafenide—Rash—Ixabepilone—breast cancer	0.000483	0.00259	CcSEcCtD
Mafenide—Dermatitis—Ixabepilone—breast cancer	0.000482	0.00258	CcSEcCtD
Mafenide—Dapsone—PTGS1—breast cancer	0.000481	0.11	CrCbGaD
Mafenide—Haemoglobin—Gemcitabine—breast cancer	0.00048	0.00257	CcSEcCtD
Mafenide—Haemorrhage—Gemcitabine—breast cancer	0.000477	0.00256	CcSEcCtD
Mafenide—Pancytopenia—Paclitaxel—breast cancer	0.000474	0.00254	CcSEcCtD
Mafenide—Pain—Chlorambucil—breast cancer	0.000474	0.00254	CcSEcCtD
Mafenide—Haemoglobin—Fluorouracil—breast cancer	0.000472	0.00253	CcSEcCtD
Mafenide—Haemorrhage—Fluorouracil—breast cancer	0.000469	0.00251	CcSEcCtD
Mafenide—Diarrhoea—Idarubicin—breast cancer	0.000468	0.00251	CcSEcCtD
Mafenide—Diarrhoea—Raloxifene—breast cancer	0.000468	0.00251	CcSEcCtD
Mafenide—Face oedema—Capecitabine—breast cancer	0.000458	0.00245	CcSEcCtD
Mafenide—Rash—Letrozole—breast cancer	0.000455	0.00243	CcSEcCtD
Mafenide—Rash—Anastrozole—breast cancer	0.000455	0.00243	CcSEcCtD
Mafenide—Dermatitis—Letrozole—breast cancer	0.000454	0.00243	CcSEcCtD
Mafenide—Dermatitis—Anastrozole—breast cancer	0.000454	0.00243	CcSEcCtD
Mafenide—Urticaria—Chlorambucil—breast cancer	0.00044	0.00236	CcSEcCtD
Mafenide—Pain—Vinblastine—breast cancer	0.000434	0.00233	CcSEcCtD
Mafenide—Rash—Raloxifene—breast cancer	0.000431	0.00231	CcSEcCtD
Mafenide—Rash—Idarubicin—breast cancer	0.000431	0.00231	CcSEcCtD
Mafenide—Dermatitis—Idarubicin—breast cancer	0.000431	0.00231	CcSEcCtD
Mafenide—Dermatitis—Raloxifene—breast cancer	0.000431	0.00231	CcSEcCtD
Mafenide—Erythema—Mitoxantrone—breast cancer	0.000426	0.00228	CcSEcCtD
Mafenide—Pain—Tamoxifen—breast cancer	0.000422	0.00226	CcSEcCtD
Mafenide—Erythema—Gemcitabine—breast cancer	0.000415	0.00222	CcSEcCtD
Mafenide—Pain—Melphalan—breast cancer	0.000413	0.00221	CcSEcCtD
Mafenide—Erythema—Fluorouracil—breast cancer	0.000408	0.00219	CcSEcCtD
Mafenide—Pain—Goserelin—breast cancer	0.000403	0.00216	CcSEcCtD
Mafenide—Pancytopenia—Docetaxel—breast cancer	0.000402	0.00215	CcSEcCtD
Mafenide—Haemoglobin—Paclitaxel—breast cancer	0.000402	0.00215	CcSEcCtD
Mafenide—Haemorrhage—Paclitaxel—breast cancer	0.0004	0.00214	CcSEcCtD
Mafenide—Pruritus—Chlorambucil—breast cancer	0.000392	0.0021	CcSEcCtD
Mafenide—Urticaria—Tamoxifen—breast cancer	0.000392	0.0021	CcSEcCtD
Mafenide—Pancytopenia—Capecitabine—breast cancer	0.000389	0.00208	CcSEcCtD
Mafenide—Urticaria—Melphalan—breast cancer	0.000384	0.00206	CcSEcCtD
Mafenide—Diarrhoea—Chlorambucil—breast cancer	0.000379	0.00203	CcSEcCtD
Mafenide—Urticaria—Goserelin—breast cancer	0.000374	0.002	CcSEcCtD
Mafenide—Sulfanilamide—CYP2D6—breast cancer	0.000367	0.0841	CrCbGaD
Mafenide—Pain—Vinorelbine—breast cancer	0.000361	0.00193	CcSEcCtD
Mafenide—Pruritus—Tamoxifen—breast cancer	0.000349	0.00187	CcSEcCtD
Mafenide—Erythema—Paclitaxel—breast cancer	0.000348	0.00186	CcSEcCtD
Mafenide—Diarrhoea—Vinblastine—breast cancer	0.000347	0.00186	CcSEcCtD
Mafenide—Dermatitis bullous—Epirubicin—breast cancer	0.000345	0.00185	CcSEcCtD
Mafenide—Pain—Thiotepa—breast cancer	0.000345	0.00185	CcSEcCtD
Mafenide—Pruritus—Melphalan—breast cancer	0.000342	0.00183	CcSEcCtD
Mafenide—Haemoglobin—Docetaxel—breast cancer	0.00034	0.00182	CcSEcCtD
Mafenide—Haemorrhage—Docetaxel—breast cancer	0.000339	0.00181	CcSEcCtD
Mafenide—Diarrhoea—Tamoxifen—breast cancer	0.000338	0.00181	CcSEcCtD
Mafenide—Urticaria—Vinorelbine—breast cancer	0.000335	0.0018	CcSEcCtD
Mafenide—Pruritus—Goserelin—breast cancer	0.000333	0.00179	CcSEcCtD
Mafenide—Diarrhoea—Melphalan—breast cancer	0.00033	0.00177	CcSEcCtD
Mafenide—Haemoglobin—Capecitabine—breast cancer	0.00033	0.00177	CcSEcCtD
Mafenide—Haemorrhage—Capecitabine—breast cancer	0.000328	0.00176	CcSEcCtD
Mafenide—Diarrhoea—Goserelin—breast cancer	0.000322	0.00173	CcSEcCtD
Mafenide—Urticaria—Thiotepa—breast cancer	0.00032	0.00171	CcSEcCtD
Mafenide—Dermatitis bullous—Doxorubicin—breast cancer	0.00032	0.00171	CcSEcCtD
Mafenide—Face oedema—Epirubicin—breast cancer	0.000319	0.00171	CcSEcCtD
Mafenide—Sulfanilamide—CYP3A4—breast cancer	0.000315	0.0722	CrCbGaD
Mafenide—Rash—Tamoxifen—breast cancer	0.000311	0.00167	CcSEcCtD
Mafenide—Dermatitis—Tamoxifen—breast cancer	0.000311	0.00166	CcSEcCtD
Mafenide—Rash—Melphalan—breast cancer	0.000305	0.00163	CcSEcCtD
Mafenide—Dermatitis—Melphalan—breast cancer	0.000304	0.00163	CcSEcCtD
Mafenide—Eosinophilia—Methotrexate—breast cancer	0.000302	0.00162	CcSEcCtD
Mafenide—Pruritus—Vinorelbine—breast cancer	0.000299	0.0016	CcSEcCtD
Mafenide—Pain—Irinotecan—breast cancer	0.000298	0.00159	CcSEcCtD
Mafenide—Pain—Mitoxantrone—breast cancer	0.000298	0.00159	CcSEcCtD
Mafenide—Rash—Goserelin—breast cancer	0.000297	0.00159	CcSEcCtD
Mafenide—Dermatitis—Goserelin—breast cancer	0.000297	0.00159	CcSEcCtD
Mafenide—Face oedema—Doxorubicin—breast cancer	0.000295	0.00158	CcSEcCtD
Mafenide—Erythema—Docetaxel—breast cancer	0.000295	0.00158	CcSEcCtD
Mafenide—Pain—Gemcitabine—breast cancer	0.00029	0.00155	CcSEcCtD
Mafenide—Pancytopenia—Methotrexate—breast cancer	0.00029	0.00155	CcSEcCtD
Mafenide—Diarrhoea—Vinorelbine—breast cancer	0.000289	0.00155	CcSEcCtD
Mafenide—Erythema—Capecitabine—breast cancer	0.000285	0.00153	CcSEcCtD
Mafenide—Pruritus—Thiotepa—breast cancer	0.000285	0.00153	CcSEcCtD
Mafenide—Pain—Fluorouracil—breast cancer	0.000285	0.00153	CcSEcCtD
Mafenide—Eosinophilia—Epirubicin—breast cancer	0.000283	0.00151	CcSEcCtD
Mafenide—Dapsone—CYP3A4—breast cancer	0.000281	0.0644	CrCbGaD
Mafenide—Urticaria—Mitoxantrone—breast cancer	0.000276	0.00148	CcSEcCtD
Mafenide—Diarrhoea—Thiotepa—breast cancer	0.000276	0.00148	CcSEcCtD
Mafenide—Dapsone—PTGS2—breast cancer	0.000275	0.063	CrCbGaD
Mafenide—Pancytopenia—Epirubicin—breast cancer	0.000271	0.00145	CcSEcCtD
Mafenide—Rash—Vinorelbine—breast cancer	0.000266	0.00143	CcSEcCtD
Mafenide—Dermatitis—Vinorelbine—breast cancer	0.000266	0.00142	CcSEcCtD
Mafenide—Urticaria—Fluorouracil—breast cancer	0.000265	0.00142	CcSEcCtD
Mafenide—Eosinophilia—Doxorubicin—breast cancer	0.000261	0.0014	CcSEcCtD
Mafenide—Rash—Thiotepa—breast cancer	0.000254	0.00136	CcSEcCtD
Mafenide—Dermatitis—Thiotepa—breast cancer	0.000254	0.00136	CcSEcCtD
Mafenide—Pancytopenia—Doxorubicin—breast cancer	0.000251	0.00134	CcSEcCtD
Mafenide—Haemoglobin—Methotrexate—breast cancer	0.000245	0.00131	CcSEcCtD
Mafenide—Haemorrhage—Methotrexate—breast cancer	0.000244	0.00131	CcSEcCtD
Mafenide—Pain—Paclitaxel—breast cancer	0.000243	0.0013	CcSEcCtD
Mafenide—Pruritus—Gemcitabine—breast cancer	0.00024	0.00128	CcSEcCtD
Mafenide—Diarrhoea—Irinotecan—breast cancer	0.000238	0.00128	CcSEcCtD
Mafenide—Diarrhoea—Mitoxantrone—breast cancer	0.000238	0.00128	CcSEcCtD
Mafenide—Pruritus—Fluorouracil—breast cancer	0.000236	0.00126	CcSEcCtD
Mafenide—Diarrhoea—Gemcitabine—breast cancer	0.000232	0.00124	CcSEcCtD
Mafenide—Haemoglobin—Epirubicin—breast cancer	0.00023	0.00123	CcSEcCtD
Mafenide—Haemorrhage—Epirubicin—breast cancer	0.000228	0.00122	CcSEcCtD
Mafenide—Diarrhoea—Fluorouracil—breast cancer	0.000228	0.00122	CcSEcCtD
Mafenide—Urticaria—Paclitaxel—breast cancer	0.000225	0.00121	CcSEcCtD
Mafenide—Rash—Mitoxantrone—breast cancer	0.000219	0.00118	CcSEcCtD
Mafenide—Rash—Irinotecan—breast cancer	0.000219	0.00118	CcSEcCtD
Mafenide—Dermatitis—Mitoxantrone—breast cancer	0.000219	0.00117	CcSEcCtD
Mafenide—Dermatitis—Irinotecan—breast cancer	0.000219	0.00117	CcSEcCtD
Mafenide—Rash—Gemcitabine—breast cancer	0.000214	0.00114	CcSEcCtD
Mafenide—Dermatitis—Gemcitabine—breast cancer	0.000214	0.00114	CcSEcCtD
Mafenide—Erythema—Methotrexate—breast cancer	0.000212	0.00114	CcSEcCtD
Mafenide—Haemoglobin—Doxorubicin—breast cancer	0.000212	0.00114	CcSEcCtD
Mafenide—Haemorrhage—Doxorubicin—breast cancer	0.000211	0.00113	CcSEcCtD
Mafenide—Rash—Fluorouracil—breast cancer	0.00021	0.00113	CcSEcCtD
Mafenide—Dermatitis—Fluorouracil—breast cancer	0.00021	0.00112	CcSEcCtD
Mafenide—Pain—Docetaxel—breast cancer	0.000206	0.0011	CcSEcCtD
Mafenide—Pruritus—Paclitaxel—breast cancer	0.000201	0.00108	CcSEcCtD
Mafenide—Pain—Capecitabine—breast cancer	0.000199	0.00107	CcSEcCtD
Mafenide—Erythema—Epirubicin—breast cancer	0.000199	0.00106	CcSEcCtD
Mafenide—Diarrhoea—Paclitaxel—breast cancer	0.000194	0.00104	CcSEcCtD
Mafenide—Urticaria—Capecitabine—breast cancer	0.000185	0.000991	CcSEcCtD
Mafenide—Erythema—Doxorubicin—breast cancer	0.000184	0.000985	CcSEcCtD
Mafenide—Rash—Paclitaxel—breast cancer	0.000179	0.000959	CcSEcCtD
Mafenide—Dermatitis—Paclitaxel—breast cancer	0.000179	0.000958	CcSEcCtD
Mafenide—Pruritus—Docetaxel—breast cancer	0.00017	0.000912	CcSEcCtD
Mafenide—Pruritus—Capecitabine—breast cancer	0.000165	0.000883	CcSEcCtD
Mafenide—Diarrhoea—Docetaxel—breast cancer	0.000165	0.000882	CcSEcCtD
Mafenide—Diarrhoea—Capecitabine—breast cancer	0.000159	0.000854	CcSEcCtD
Mafenide—Rash—Docetaxel—breast cancer	0.000152	0.000812	CcSEcCtD
Mafenide—Dermatitis—Docetaxel—breast cancer	0.000152	0.000812	CcSEcCtD
Mafenide—Pain—Methotrexate—breast cancer	0.000148	0.000794	CcSEcCtD
Mafenide—Rash—Capecitabine—breast cancer	0.000147	0.000787	CcSEcCtD
Mafenide—Dermatitis—Capecitabine—breast cancer	0.000147	0.000786	CcSEcCtD
Mafenide—Pain—Epirubicin—breast cancer	0.000139	0.000743	CcSEcCtD
Mafenide—Urticaria—Methotrexate—breast cancer	0.000138	0.000738	CcSEcCtD
Mafenide—Urticaria—Epirubicin—breast cancer	0.000129	0.00069	CcSEcCtD
Mafenide—Pain—Doxorubicin—breast cancer	0.000128	0.000688	CcSEcCtD
Mafenide—Pruritus—Methotrexate—breast cancer	0.000123	0.000657	CcSEcCtD
Mafenide—Urticaria—Doxorubicin—breast cancer	0.000119	0.000639	CcSEcCtD
Mafenide—Diarrhoea—Methotrexate—breast cancer	0.000119	0.000635	CcSEcCtD
Mafenide—Pruritus—Epirubicin—breast cancer	0.000115	0.000615	CcSEcCtD
Mafenide—Diarrhoea—Epirubicin—breast cancer	0.000111	0.000595	CcSEcCtD
Mafenide—Rash—Methotrexate—breast cancer	0.000109	0.000586	CcSEcCtD
Mafenide—Dermatitis—Methotrexate—breast cancer	0.000109	0.000585	CcSEcCtD
Mafenide—Pruritus—Doxorubicin—breast cancer	0.000106	0.000569	CcSEcCtD
Mafenide—Diarrhoea—Doxorubicin—breast cancer	0.000103	0.00055	CcSEcCtD
Mafenide—Rash—Epirubicin—breast cancer	0.000102	0.000548	CcSEcCtD
Mafenide—Dermatitis—Epirubicin—breast cancer	0.000102	0.000548	CcSEcCtD
Mafenide—Rash—Doxorubicin—breast cancer	9.47e-05	0.000507	CcSEcCtD
Mafenide—Dermatitis—Doxorubicin—breast cancer	9.46e-05	0.000507	CcSEcCtD
Mafenide—CA9—Metabolism—HPSE—breast cancer	6.68e-05	0.000986	CbGpPWpGaD
Mafenide—CA9—Metabolism—BRIP1—breast cancer	6.68e-05	0.000986	CbGpPWpGaD
Mafenide—CA12—Metabolism—HPGDS—breast cancer	6.68e-05	0.000986	CbGpPWpGaD
Mafenide—CA12—Metabolism—HBA1—breast cancer	6.64e-05	0.000979	CbGpPWpGaD
Mafenide—CA7—Metabolism—CYP17A1—breast cancer	6.62e-05	0.000977	CbGpPWpGaD
Mafenide—CA2—Metabolism—GPX4—breast cancer	6.61e-05	0.000976	CbGpPWpGaD
Mafenide—CA2—Metabolism—SULT1A1—breast cancer	6.61e-05	0.000976	CbGpPWpGaD
Mafenide—CA7—Metabolism—PTGS1—breast cancer	6.55e-05	0.000967	CbGpPWpGaD
Mafenide—CA7—Metabolism—ENO1—breast cancer	6.55e-05	0.000967	CbGpPWpGaD
Mafenide—CA6—Metabolism—FASN—breast cancer	6.55e-05	0.000967	CbGpPWpGaD
Mafenide—CA6—Metabolism—BCHE—breast cancer	6.52e-05	0.000963	CbGpPWpGaD
Mafenide—CA12—Metabolism—ACHE—breast cancer	6.48e-05	0.000956	CbGpPWpGaD
Mafenide—CA12—Metabolism—GSTT1—breast cancer	6.48e-05	0.000956	CbGpPWpGaD
Mafenide—CA2—Metabolism—GSTA1—breast cancer	6.46e-05	0.000953	CbGpPWpGaD
Mafenide—CA2—Metabolism—IDH1—breast cancer	6.46e-05	0.000953	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—MDM2—breast cancer	6.45e-05	0.000952	CbGpPWpGaD
Mafenide—CA6—Metabolism—SLC5A5—breast cancer	6.44e-05	0.000951	CbGpPWpGaD
Mafenide—CA7—Metabolism—CYP2D6—breast cancer	6.42e-05	0.000948	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—RELA—breast cancer	6.4e-05	0.000945	CbGpPWpGaD
Mafenide—CA2—Metabolism—NAT2—breast cancer	6.39e-05	0.000943	CbGpPWpGaD
Mafenide—CA9—Metabolism—GSTA3—breast cancer	6.33e-05	0.000934	CbGpPWpGaD
Mafenide—CA9—Metabolism—ABCC1—breast cancer	6.33e-05	0.000934	CbGpPWpGaD
Mafenide—CA9—Metabolism—HMMR—breast cancer	6.33e-05	0.000934	CbGpPWpGaD
Mafenide—CA7—Metabolism—NCOA2—breast cancer	6.31e-05	0.000931	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—MTOR—breast cancer	6.28e-05	0.000927	CbGpPWpGaD
Mafenide—CA6—Metabolism—SLC2A1—breast cancer	6.22e-05	0.000919	CbGpPWpGaD
Mafenide—CA6—Metabolism—NQO1—breast cancer	6.22e-05	0.000919	CbGpPWpGaD
Mafenide—CA12—Metabolism—CYP17A1—breast cancer	6.13e-05	0.000905	CbGpPWpGaD
Mafenide—CA9—Metabolism—PPARGC1B—breast cancer	6.13e-05	0.000905	CbGpPWpGaD
Mafenide—CA7—Metabolism—FASN—breast cancer	6.12e-05	0.000903	CbGpPWpGaD
Mafenide—CA7—Metabolism—BCHE—breast cancer	6.09e-05	0.000899	CbGpPWpGaD
Mafenide—CA6—Metabolism—CYP3A4—breast cancer	6.07e-05	0.000896	CbGpPWpGaD
Mafenide—CA12—Metabolism—ENO1—breast cancer	6.07e-05	0.000896	CbGpPWpGaD
Mafenide—CA12—Metabolism—PTGS1—breast cancer	6.07e-05	0.000896	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—CXCL8—breast cancer	6.03e-05	0.00089	CbGpPWpGaD
Mafenide—CA7—Metabolism—SLC5A5—breast cancer	6.02e-05	0.000888	CbGpPWpGaD
Mafenide—CA6—Metabolism—CYP1B1—breast cancer	5.97e-05	0.000881	CbGpPWpGaD
Mafenide—CA12—Metabolism—CYP2D6—breast cancer	5.95e-05	0.000878	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—CDKN1B—breast cancer	5.89e-05	0.00087	CbGpPWpGaD
Mafenide—CA6—Metabolism—HSP90AA1—breast cancer	5.85e-05	0.000864	CbGpPWpGaD
Mafenide—CA12—Metabolism—NCOA2—breast cancer	5.84e-05	0.000862	CbGpPWpGaD
Mafenide—CA7—Metabolism—SLC2A1—breast cancer	5.81e-05	0.000857	CbGpPWpGaD
Mafenide—CA7—Metabolism—NQO1—breast cancer	5.81e-05	0.000857	CbGpPWpGaD
Mafenide—CA9—Metabolism—GSTA4—breast cancer	5.79e-05	0.000855	CbGpPWpGaD
Mafenide—CA6—Metabolism—NCOA1—breast cancer	5.69e-05	0.00084	CbGpPWpGaD
Mafenide—CA7—Metabolism—CYP3A4—breast cancer	5.67e-05	0.000836	CbGpPWpGaD
Mafenide—CA12—Metabolism—FASN—breast cancer	5.67e-05	0.000836	CbGpPWpGaD
Mafenide—CA9—Metabolism—GPX2—breast cancer	5.64e-05	0.000833	CbGpPWpGaD
Mafenide—CA12—Metabolism—BCHE—breast cancer	5.64e-05	0.000833	CbGpPWpGaD
Mafenide—CA9—Metabolism—GSTA2—breast cancer	5.64e-05	0.000833	CbGpPWpGaD
Mafenide—CA6—Metabolism—STK11—breast cancer	5.61e-05	0.000828	CbGpPWpGaD
Mafenide—CA6—Metabolism—CYP19A1—breast cancer	5.61e-05	0.000828	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—JUN—breast cancer	5.61e-05	0.000828	CbGpPWpGaD
Mafenide—CA2—Metabolism—MED12—breast cancer	5.6e-05	0.000826	CbGpPWpGaD
Mafenide—CA2—Metabolism—DPYD—breast cancer	5.6e-05	0.000826	CbGpPWpGaD
Mafenide—CA9—Metabolism—GPX4—breast cancer	5.57e-05	0.000823	CbGpPWpGaD
Mafenide—CA9—Metabolism—SULT1A1—breast cancer	5.57e-05	0.000823	CbGpPWpGaD
Mafenide—CA12—Metabolism—SLC5A5—breast cancer	5.57e-05	0.000823	CbGpPWpGaD
Mafenide—CA7—Metabolism—CYP1B1—breast cancer	5.57e-05	0.000822	CbGpPWpGaD
Mafenide—CA2—Metabolism—ALDOA—breast cancer	5.51e-05	0.000814	CbGpPWpGaD
Mafenide—CA7—Metabolism—HSP90AA1—breast cancer	5.46e-05	0.000806	CbGpPWpGaD
Mafenide—CA9—Metabolism—IDH1—breast cancer	5.44e-05	0.000803	CbGpPWpGaD
Mafenide—CA9—Metabolism—GSTA1—breast cancer	5.44e-05	0.000803	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—CDKN1A—breast cancer	5.44e-05	0.000802	CbGpPWpGaD
Mafenide—CA9—Metabolism—NAT2—breast cancer	5.38e-05	0.000794	CbGpPWpGaD
Mafenide—CA12—Metabolism—SLC2A1—breast cancer	5.38e-05	0.000794	CbGpPWpGaD
Mafenide—CA12—Metabolism—NQO1—breast cancer	5.38e-05	0.000794	CbGpPWpGaD
Mafenide—CA2—Metabolism—NCOA3—breast cancer	5.35e-05	0.00079	CbGpPWpGaD
Mafenide—CA7—Metabolism—NCOA1—breast cancer	5.31e-05	0.000784	CbGpPWpGaD
Mafenide—CA2—Metabolism—SLC2A2—breast cancer	5.31e-05	0.000784	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—MAPK8—breast cancer	5.31e-05	0.000783	CbGpPWpGaD
Mafenide—CA12—Metabolism—CYP3A4—breast cancer	5.25e-05	0.000775	CbGpPWpGaD
Mafenide—CA7—Metabolism—CYP19A1—breast cancer	5.24e-05	0.000773	CbGpPWpGaD
Mafenide—CA7—Metabolism—STK11—breast cancer	5.24e-05	0.000773	CbGpPWpGaD
Mafenide—CA6—Metabolism—COMT—breast cancer	5.21e-05	0.00077	CbGpPWpGaD
Mafenide—CA2—Metabolism—CPT1A—breast cancer	5.21e-05	0.000768	CbGpPWpGaD
Mafenide—CA2—Metabolism—MTR—breast cancer	5.21e-05	0.000768	CbGpPWpGaD
Mafenide—CA2—Metabolism—ABCG2—breast cancer	5.21e-05	0.000768	CbGpPWpGaD
Mafenide—CA6—Metabolism—GSTP1—breast cancer	5.19e-05	0.000766	CbGpPWpGaD
Mafenide—CA12—Metabolism—CYP1B1—breast cancer	5.16e-05	0.000762	CbGpPWpGaD
Mafenide—CA6—Metabolism—HMOX1—breast cancer	5.12e-05	0.000756	CbGpPWpGaD
Mafenide—CA6—Metabolism—ITPR1—breast cancer	5.11e-05	0.000754	CbGpPWpGaD
Mafenide—CA2—Metabolism—HPGDS—breast cancer	5.1e-05	0.000753	CbGpPWpGaD
Mafenide—CA2—Metabolism—HBA1—breast cancer	5.07e-05	0.000749	CbGpPWpGaD
Mafenide—CA12—Metabolism—HSP90AA1—breast cancer	5.06e-05	0.000747	CbGpPWpGaD
Mafenide—CA2—Metabolism—ACHE—breast cancer	4.95e-05	0.000731	CbGpPWpGaD
Mafenide—CA2—Metabolism—GSTT1—breast cancer	4.95e-05	0.000731	CbGpPWpGaD
Mafenide—CA12—Metabolism—NCOA1—breast cancer	4.92e-05	0.000727	CbGpPWpGaD
Mafenide—CA6—Metabolism—ABCB1—breast cancer	4.91e-05	0.000725	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—VEGFA—breast cancer	4.9e-05	0.000723	CbGpPWpGaD
Mafenide—CA7—Metabolism—COMT—breast cancer	4.87e-05	0.000719	CbGpPWpGaD
Mafenide—CA12—Metabolism—CYP19A1—breast cancer	4.85e-05	0.000716	CbGpPWpGaD
Mafenide—CA12—Metabolism—STK11—breast cancer	4.85e-05	0.000716	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—STAT3—breast cancer	4.85e-05	0.000716	CbGpPWpGaD
Mafenide—CA7—Metabolism—GSTP1—breast cancer	4.85e-05	0.000715	CbGpPWpGaD
Mafenide—CA6—Metabolism—TYMS—breast cancer	4.83e-05	0.000712	CbGpPWpGaD
Mafenide—CA7—Metabolism—HMOX1—breast cancer	4.78e-05	0.000705	CbGpPWpGaD
Mafenide—CA6—Metabolism—PLA2G4A—breast cancer	4.77e-05	0.000704	CbGpPWpGaD
Mafenide—CA6—Metabolism—GSTM1—breast cancer	4.77e-05	0.000704	CbGpPWpGaD
Mafenide—CA6—Metabolism—NCOR1—breast cancer	4.77e-05	0.000704	CbGpPWpGaD
Mafenide—CA7—Metabolism—ITPR1—breast cancer	4.77e-05	0.000704	CbGpPWpGaD
Mafenide—CA9—Metabolism—MED12—breast cancer	4.72e-05	0.000697	CbGpPWpGaD
Mafenide—CA9—Metabolism—DPYD—breast cancer	4.72e-05	0.000697	CbGpPWpGaD
Mafenide—CA2—Metabolism—CYP17A1—breast cancer	4.69e-05	0.000692	CbGpPWpGaD
Mafenide—CA9—Metabolism—ALDOA—breast cancer	4.65e-05	0.000686	CbGpPWpGaD
Mafenide—CA2—Metabolism—ENO1—breast cancer	4.64e-05	0.000685	CbGpPWpGaD
Mafenide—CA2—Metabolism—PTGS1—breast cancer	4.64e-05	0.000685	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—MAPK3—breast cancer	4.63e-05	0.000684	CbGpPWpGaD
Mafenide—CA7—Metabolism—ABCB1—breast cancer	4.59e-05	0.000677	CbGpPWpGaD
Mafenide—CA6—Metabolism—GPX1—breast cancer	4.57e-05	0.000674	CbGpPWpGaD
Mafenide—CA2—Metabolism—CYP2D6—breast cancer	4.55e-05	0.000672	CbGpPWpGaD
Mafenide—CA6—Metabolism—CYP1A1—breast cancer	4.52e-05	0.000667	CbGpPWpGaD
Mafenide—CA9—Metabolism—NCOA3—breast cancer	4.51e-05	0.000666	CbGpPWpGaD
Mafenide—CA12—Metabolism—COMT—breast cancer	4.51e-05	0.000666	CbGpPWpGaD
Mafenide—CA7—Metabolism—TYMS—breast cancer	4.5e-05	0.000665	CbGpPWpGaD
Mafenide—CA12—Metabolism—GSTP1—breast cancer	4.49e-05	0.000663	CbGpPWpGaD
Mafenide—CA6—Metabolism—ERCC2—breast cancer	4.48e-05	0.000662	CbGpPWpGaD
Mafenide—CA9—Metabolism—SLC2A2—breast cancer	4.48e-05	0.000661	CbGpPWpGaD
Mafenide—CA2—Metabolism—NCOA2—breast cancer	4.47e-05	0.000659	CbGpPWpGaD
Mafenide—CA7—Metabolism—PLA2G4A—breast cancer	4.45e-05	0.000657	CbGpPWpGaD
Mafenide—CA7—Metabolism—GSTM1—breast cancer	4.45e-05	0.000657	CbGpPWpGaD
Mafenide—CA7—Metabolism—NCOR1—breast cancer	4.45e-05	0.000657	CbGpPWpGaD
Mafenide—CA12—Metabolism—HMOX1—breast cancer	4.43e-05	0.000653	CbGpPWpGaD
Mafenide—CA12—Metabolism—ITPR1—breast cancer	4.42e-05	0.000652	CbGpPWpGaD
Mafenide—CA9—Metabolism—ABCG2—breast cancer	4.39e-05	0.000648	CbGpPWpGaD
Mafenide—CA9—Metabolism—CPT1A—breast cancer	4.39e-05	0.000648	CbGpPWpGaD
Mafenide—CA9—Metabolism—MTR—breast cancer	4.39e-05	0.000648	CbGpPWpGaD
Mafenide—CA2—Metabolism—FASN—breast cancer	4.33e-05	0.000639	CbGpPWpGaD
Mafenide—CA2—Metabolism—BCHE—breast cancer	4.31e-05	0.000637	CbGpPWpGaD
Mafenide—CA9—Metabolism—HPGDS—breast cancer	4.3e-05	0.000635	CbGpPWpGaD
Mafenide—CA9—Metabolism—HBA1—breast cancer	4.28e-05	0.000631	CbGpPWpGaD
Mafenide—CA7—Metabolism—GPX1—breast cancer	4.26e-05	0.000629	CbGpPWpGaD
Mafenide—CA2—Metabolism—SLC5A5—breast cancer	4.26e-05	0.000629	CbGpPWpGaD
Mafenide—CA12—Metabolism—ABCB1—breast cancer	4.25e-05	0.000627	CbGpPWpGaD
Mafenide—CA7—Metabolism—CYP1A1—breast cancer	4.22e-05	0.000623	CbGpPWpGaD
Mafenide—CA6—Metabolism—MTHFR—breast cancer	4.22e-05	0.000622	CbGpPWpGaD
Mafenide—CA7—Metabolism—ERCC2—breast cancer	4.19e-05	0.000618	CbGpPWpGaD
Mafenide—CA9—Metabolism—ACHE—breast cancer	4.17e-05	0.000616	CbGpPWpGaD
Mafenide—CA12—Metabolism—TYMS—breast cancer	4.17e-05	0.000616	CbGpPWpGaD
Mafenide—CA9—Metabolism—GSTT1—breast cancer	4.17e-05	0.000616	CbGpPWpGaD
Mafenide—CA12—Metabolism—NCOR1—breast cancer	4.13e-05	0.000609	CbGpPWpGaD
Mafenide—CA12—Metabolism—GSTM1—breast cancer	4.13e-05	0.000609	CbGpPWpGaD
Mafenide—CA12—Metabolism—PLA2G4A—breast cancer	4.13e-05	0.000609	CbGpPWpGaD
Mafenide—CA2—Metabolism—NQO1—breast cancer	4.11e-05	0.000607	CbGpPWpGaD
Mafenide—CA2—Metabolism—SLC2A1—breast cancer	4.11e-05	0.000607	CbGpPWpGaD
Mafenide—CA2—Metabolism—CYP3A4—breast cancer	4.01e-05	0.000592	CbGpPWpGaD
Mafenide—CA12—Metabolism—GPX1—breast cancer	3.95e-05	0.000583	CbGpPWpGaD
Mafenide—CA9—Metabolism—CYP17A1—breast cancer	3.95e-05	0.000583	CbGpPWpGaD
Mafenide—CA2—Metabolism—CYP1B1—breast cancer	3.94e-05	0.000582	CbGpPWpGaD
Mafenide—CA7—Metabolism—MTHFR—breast cancer	3.94e-05	0.000581	CbGpPWpGaD
Mafenide—CA9—Metabolism—ENO1—breast cancer	3.91e-05	0.000577	CbGpPWpGaD
Mafenide—CA9—Metabolism—PTGS1—breast cancer	3.91e-05	0.000577	CbGpPWpGaD
Mafenide—CA12—Metabolism—CYP1A1—breast cancer	3.91e-05	0.000577	CbGpPWpGaD
Mafenide—CA6—Metabolism—CAV1—breast cancer	3.89e-05	0.000574	CbGpPWpGaD
Mafenide—CA12—Metabolism—ERCC2—breast cancer	3.88e-05	0.000572	CbGpPWpGaD
Mafenide—CA2—Metabolism—HSP90AA1—breast cancer	3.87e-05	0.000571	CbGpPWpGaD
Mafenide—CA9—Metabolism—CYP2D6—breast cancer	3.83e-05	0.000566	CbGpPWpGaD
Mafenide—CA9—Metabolism—NCOA2—breast cancer	3.76e-05	0.000556	CbGpPWpGaD
Mafenide—CA2—Metabolism—NCOA1—breast cancer	3.76e-05	0.000555	CbGpPWpGaD
Mafenide—CA2—Metabolism—STK11—breast cancer	3.71e-05	0.000547	CbGpPWpGaD
Mafenide—CA2—Metabolism—CYP19A1—breast cancer	3.71e-05	0.000547	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—TP53—breast cancer	3.7e-05	0.000546	CbGpPWpGaD
Mafenide—CA9—Metabolism—FASN—breast cancer	3.65e-05	0.000539	CbGpPWpGaD
Mafenide—CA12—Metabolism—MTHFR—breast cancer	3.65e-05	0.000538	CbGpPWpGaD
Mafenide—CA9—Metabolism—BCHE—breast cancer	3.64e-05	0.000537	CbGpPWpGaD
Mafenide—CA7—Metabolism—CAV1—breast cancer	3.63e-05	0.000536	CbGpPWpGaD
Mafenide—CA9—Metabolism—SLC5A5—breast cancer	3.59e-05	0.00053	CbGpPWpGaD
Mafenide—CA6—Metabolism—PIK3CG—breast cancer	3.54e-05	0.000523	CbGpPWpGaD
Mafenide—CA9—Metabolism—NQO1—breast cancer	3.47e-05	0.000512	CbGpPWpGaD
Mafenide—CA9—Metabolism—SLC2A1—breast cancer	3.47e-05	0.000512	CbGpPWpGaD
Mafenide—CA2—Metabolism—COMT—breast cancer	3.45e-05	0.000509	CbGpPWpGaD
Mafenide—CA2—Metabolism—GSTP1—breast cancer	3.43e-05	0.000507	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—IL6—breast cancer	3.39e-05	0.0005	CbGpPWpGaD
Mafenide—CA2—Metabolism—HMOX1—breast cancer	3.38e-05	0.0005	CbGpPWpGaD
Mafenide—CA9—Metabolism—CYP3A4—breast cancer	3.38e-05	0.000499	CbGpPWpGaD
Mafenide—CA2—Metabolism—ITPR1—breast cancer	3.38e-05	0.000498	CbGpPWpGaD
Mafenide—CA12—Metabolism—CAV1—breast cancer	3.36e-05	0.000496	CbGpPWpGaD
Mafenide—CA9—Metabolism—CYP1B1—breast cancer	3.33e-05	0.000491	CbGpPWpGaD
Mafenide—CA7—Metabolism—PIK3CG—breast cancer	3.31e-05	0.000488	CbGpPWpGaD
Mafenide—CA9—Metabolism—HSP90AA1—breast cancer	3.26e-05	0.000481	CbGpPWpGaD
Mafenide—CA2—Metabolism—ABCB1—breast cancer	3.25e-05	0.00048	CbGpPWpGaD
Mafenide—CA2—Metabolism—TYMS—breast cancer	3.19e-05	0.000471	CbGpPWpGaD
Mafenide—CA9—Metabolism—NCOA1—breast cancer	3.17e-05	0.000468	CbGpPWpGaD
Mafenide—CA2—Metabolism—GSTM1—breast cancer	3.15e-05	0.000466	CbGpPWpGaD
Mafenide—CA2—Metabolism—PLA2G4A—breast cancer	3.15e-05	0.000466	CbGpPWpGaD
Mafenide—CA2—Metabolism—NCOR1—breast cancer	3.15e-05	0.000466	CbGpPWpGaD
Mafenide—CA9—Metabolism—STK11—breast cancer	3.13e-05	0.000461	CbGpPWpGaD
Mafenide—CA9—Metabolism—CYP19A1—breast cancer	3.13e-05	0.000461	CbGpPWpGaD
Mafenide—CA6—Metabolism—PIK3CD—breast cancer	3.11e-05	0.00046	CbGpPWpGaD
Mafenide—CA6—Metabolism—ALB—breast cancer	3.07e-05	0.000454	CbGpPWpGaD
Mafenide—CA12—Metabolism—PIK3CG—breast cancer	3.06e-05	0.000452	CbGpPWpGaD
Mafenide—CA2—Metabolism—GPX1—breast cancer	3.02e-05	0.000446	CbGpPWpGaD
Mafenide—CA2—Metabolism—CYP1A1—breast cancer	2.99e-05	0.000441	CbGpPWpGaD
Mafenide—CA2—Metabolism—ERCC2—breast cancer	2.97e-05	0.000438	CbGpPWpGaD
Mafenide—CA6—Metabolism—NOS3—breast cancer	2.94e-05	0.000434	CbGpPWpGaD
Mafenide—CA7—Metabolism—PIK3CD—breast cancer	2.91e-05	0.000429	CbGpPWpGaD
Mafenide—CA9—Metabolism—COMT—breast cancer	2.91e-05	0.000429	CbGpPWpGaD
Mafenide—CA9—Metabolism—GSTP1—breast cancer	2.89e-05	0.000427	CbGpPWpGaD
Mafenide—CA7—Metabolism—ALB—breast cancer	2.87e-05	0.000424	CbGpPWpGaD
Mafenide—CA9—Metabolism—HMOX1—breast cancer	2.85e-05	0.000421	CbGpPWpGaD
Mafenide—CA9—Metabolism—ITPR1—breast cancer	2.85e-05	0.00042	CbGpPWpGaD
Mafenide—CA2—Metabolism—MTHFR—breast cancer	2.79e-05	0.000411	CbGpPWpGaD
Mafenide—CA7—Metabolism—NOS3—breast cancer	2.74e-05	0.000405	CbGpPWpGaD
Mafenide—CA9—Metabolism—ABCB1—breast cancer	2.74e-05	0.000404	CbGpPWpGaD
Mafenide—CA6—Metabolism—PIK3CB—breast cancer	2.71e-05	0.000401	CbGpPWpGaD
Mafenide—CA12—Metabolism—PIK3CD—breast cancer	2.69e-05	0.000397	CbGpPWpGaD
Mafenide—CA9—Metabolism—TYMS—breast cancer	2.69e-05	0.000397	CbGpPWpGaD
Mafenide—CA6—Metabolism—PTGS2—breast cancer	2.69e-05	0.000397	CbGpPWpGaD
Mafenide—CA9—Metabolism—GSTM1—breast cancer	2.66e-05	0.000392	CbGpPWpGaD
Mafenide—CA9—Metabolism—NCOR1—breast cancer	2.66e-05	0.000392	CbGpPWpGaD
Mafenide—CA9—Metabolism—PLA2G4A—breast cancer	2.66e-05	0.000392	CbGpPWpGaD
Mafenide—CA12—Metabolism—ALB—breast cancer	2.66e-05	0.000392	CbGpPWpGaD
Mafenide—CA2—Metabolism—CAV1—breast cancer	2.57e-05	0.000379	CbGpPWpGaD
Mafenide—CA9—Metabolism—GPX1—breast cancer	2.55e-05	0.000376	CbGpPWpGaD
Mafenide—CA12—Metabolism—NOS3—breast cancer	2.54e-05	0.000375	CbGpPWpGaD
Mafenide—CA7—Metabolism—PIK3CB—breast cancer	2.53e-05	0.000374	CbGpPWpGaD
Mafenide—CA9—Metabolism—CYP1A1—breast cancer	2.52e-05	0.000372	CbGpPWpGaD
Mafenide—CA7—Metabolism—PTGS2—breast cancer	2.51e-05	0.000371	CbGpPWpGaD
Mafenide—CA9—Metabolism—ERCC2—breast cancer	2.5e-05	0.000369	CbGpPWpGaD
Mafenide—CA9—Metabolism—MTHFR—breast cancer	2.35e-05	0.000347	CbGpPWpGaD
Mafenide—CA12—Metabolism—PIK3CB—breast cancer	2.35e-05	0.000346	CbGpPWpGaD
Mafenide—CA6—Metabolism—PTEN—breast cancer	2.34e-05	0.000346	CbGpPWpGaD
Mafenide—CA2—Metabolism—PIK3CG—breast cancer	2.34e-05	0.000346	CbGpPWpGaD
Mafenide—CA12—Metabolism—PTGS2—breast cancer	2.33e-05	0.000343	CbGpPWpGaD
Mafenide—CA7—Metabolism—PTEN—breast cancer	2.19e-05	0.000323	CbGpPWpGaD
Mafenide—CA9—Metabolism—CAV1—breast cancer	2.17e-05	0.00032	CbGpPWpGaD
Mafenide—CA2—Metabolism—PIK3CD—breast cancer	2.06e-05	0.000304	CbGpPWpGaD
Mafenide—CA2—Metabolism—ALB—breast cancer	2.03e-05	0.0003	CbGpPWpGaD
Mafenide—CA12—Metabolism—PTEN—breast cancer	2.03e-05	0.000299	CbGpPWpGaD
Mafenide—CA9—Metabolism—PIK3CG—breast cancer	1.97e-05	0.000291	CbGpPWpGaD
Mafenide—CA2—Metabolism—NOS3—breast cancer	1.94e-05	0.000287	CbGpPWpGaD
Mafenide—CA2—Metabolism—PIK3CB—breast cancer	1.79e-05	0.000265	CbGpPWpGaD
Mafenide—CA2—Metabolism—PTGS2—breast cancer	1.78e-05	0.000262	CbGpPWpGaD
Mafenide—CA9—Metabolism—PIK3CD—breast cancer	1.74e-05	0.000256	CbGpPWpGaD
Mafenide—CA9—Metabolism—ALB—breast cancer	1.71e-05	0.000253	CbGpPWpGaD
Mafenide—CA6—Metabolism—PIK3CA—breast cancer	1.65e-05	0.000244	CbGpPWpGaD
Mafenide—CA9—Metabolism—NOS3—breast cancer	1.64e-05	0.000242	CbGpPWpGaD
Mafenide—CA2—Metabolism—PTEN—breast cancer	1.55e-05	0.000229	CbGpPWpGaD
Mafenide—CA7—Metabolism—PIK3CA—breast cancer	1.54e-05	0.000228	CbGpPWpGaD
Mafenide—CA9—Metabolism—PIK3CB—breast cancer	1.51e-05	0.000223	CbGpPWpGaD
Mafenide—CA9—Metabolism—PTGS2—breast cancer	1.5e-05	0.000221	CbGpPWpGaD
Mafenide—CA12—Metabolism—PIK3CA—breast cancer	1.43e-05	0.000211	CbGpPWpGaD
Mafenide—CA6—Metabolism—AKT1—breast cancer	1.35e-05	0.000199	CbGpPWpGaD
Mafenide—CA9—Metabolism—PTEN—breast cancer	1.31e-05	0.000193	CbGpPWpGaD
Mafenide—CA7—Metabolism—AKT1—breast cancer	1.26e-05	0.000186	CbGpPWpGaD
Mafenide—CA12—Metabolism—AKT1—breast cancer	1.17e-05	0.000173	CbGpPWpGaD
Mafenide—CA2—Metabolism—PIK3CA—breast cancer	1.09e-05	0.000161	CbGpPWpGaD
Mafenide—CA9—Metabolism—PIK3CA—breast cancer	9.22e-06	0.000136	CbGpPWpGaD
Mafenide—CA2—Metabolism—AKT1—breast cancer	8.94e-06	0.000132	CbGpPWpGaD
Mafenide—CA9—Metabolism—AKT1—breast cancer	7.53e-06	0.000111	CbGpPWpGaD
